Rekombinanter Prosaposin Antikörper (AA 200-400)
Kurzübersicht für Rekombinanter Prosaposin Antikörper (AA 200-400) (ABIN7872036)
Target
Alle Prosaposin (PSAP) Antikörper anzeigenAntikörpertyp
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
Klon
-
-
Bindungsspezifität
- AA 200-400
-
Verwendungszweck
- PSAP Antibody / ACP3 / Prostate Specific Acid Phosphatase (azide and preservative free)
-
Aufreinigung
- Protein A/G affinity
-
Immunogen
- A recombinant partial protein sequence (within amino acids 200-400) from the human protein was used as the immunogen for the PSAP antibody.
-
Isotyp
- IgG, kappa
-
-
-
-
Applikationshinweise
- Optimal dilution of the PSAP antibody should be determined by the researcher.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Konservierungsmittel
- Azide free
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot the PSAP antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- Prosaposin (PSAP)
-
Andere Bezeichnung
- PSAP
-
Hintergrund
- Prostatic Acid Phosphatase (PSAP or PAP) is a member of the histidine acid phosphatase family. It is a non-specific phosphatase that is capable of dephosphorylating tyrosine residues as well as phospholipids under mildly acidic conditions. Prostatic specific acid phosphatase (PSAP) is involved in prostate epithelial differentiation. It is highly expressed in prostate, primary and metastatic carcinoma of the prostate. This marker may be helpful in pinpointing the site of origin in cases of metastatic carcinoma of the prostate, and is considered a more sensitive marker than PSA.
-
UniProt
- P15309
-
Pathways
- Positive Regulation of Endopeptidase Activity
Target
-